Starburst amacrine cells, involved in visual motion perception, lose their synaptic input from dopaminergic amacrine cells and degenerate in Parkinson’s disease patients
Background The main clinical symptoms characteristic of Parkinson’s disease (PD) are bradykinesia, tremor, and other motor deficits. However, non-motor symptoms, such as visual disturbances, can be identified at early stages of the disease. One of these symptoms is the impairment of visual motion pe...
Saved in:
Published in | Translational neurodegeneration Vol. 12; no. 1; pp. 1 - 16 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
London
BioMed Central
03.04.2023
BMC |
Subjects | |
Online Access | Get full text |
ISSN | 2047-9158 2047-9158 |
DOI | 10.1186/s40035-023-00348-y |
Cover
Abstract | Background
The main clinical symptoms characteristic of Parkinson’s disease (PD) are bradykinesia, tremor, and other motor deficits. However, non-motor symptoms, such as visual disturbances, can be identified at early stages of the disease. One of these symptoms is the impairment of visual motion perception. Hence, we sought to determine if the starburst amacrine cells, which are the main cellular type involved in motion direction selectivity, are degenerated in PD and if the dopaminergic system is related to this degeneration.
Methods
Human eyes from control (
n
= 10) and PD (
n
= 9) donors were available for this study. Using immunohistochemistry and confocal microscopy, we quantified starburst amacrine cell density (choline acetyltransferase [ChAT]-positive cells) and the relationship between these cells and dopaminergic amacrine cells (tyrosine hydroxylase-positive cells and vesicular monoamine transporter-2-positive presynapses) in cross-sections and wholemount retinas.
Results
First, we found two different ChAT amacrine populations in the human retina that presented different ChAT immunoreactivity intensity and different expression of calcium-binding proteins. Both populations are affected in PD and their density is reduced compared to controls. Also, we report, for the first time, synaptic contacts between dopaminergic amacrine cells and ChAT-positive cells in the human retina. We found that, in PD retinas, there is a reduction of the dopaminergic synaptic contacts into ChAT cells.
Conclusions
Taken together, this work indicates degeneration of starburst amacrine cells in PD related to dopaminergic degeneration and that dopaminergic amacrine cells could modulate the function of starburst amacrine cells. Since motion perception circuitries are affected in PD, their assessment using visual tests could provide new insights into the diagnosis of PD. |
---|---|
AbstractList | Abstract Background The main clinical symptoms characteristic of Parkinson’s disease (PD) are bradykinesia, tremor, and other motor deficits. However, non-motor symptoms, such as visual disturbances, can be identified at early stages of the disease. One of these symptoms is the impairment of visual motion perception. Hence, we sought to determine if the starburst amacrine cells, which are the main cellular type involved in motion direction selectivity, are degenerated in PD and if the dopaminergic system is related to this degeneration. Methods Human eyes from control (n = 10) and PD (n = 9) donors were available for this study. Using immunohistochemistry and confocal microscopy, we quantified starburst amacrine cell density (choline acetyltransferase [ChAT]-positive cells) and the relationship between these cells and dopaminergic amacrine cells (tyrosine hydroxylase-positive cells and vesicular monoamine transporter-2-positive presynapses) in cross-sections and wholemount retinas. Results First, we found two different ChAT amacrine populations in the human retina that presented different ChAT immunoreactivity intensity and different expression of calcium-binding proteins. Both populations are affected in PD and their density is reduced compared to controls. Also, we report, for the first time, synaptic contacts between dopaminergic amacrine cells and ChAT-positive cells in the human retina. We found that, in PD retinas, there is a reduction of the dopaminergic synaptic contacts into ChAT cells. Conclusions Taken together, this work indicates degeneration of starburst amacrine cells in PD related to dopaminergic degeneration and that dopaminergic amacrine cells could modulate the function of starburst amacrine cells. Since motion perception circuitries are affected in PD, their assessment using visual tests could provide new insights into the diagnosis of PD. Background The main clinical symptoms characteristic of Parkinson’s disease (PD) are bradykinesia, tremor, and other motor deficits. However, non-motor symptoms, such as visual disturbances, can be identified at early stages of the disease. One of these symptoms is the impairment of visual motion perception. Hence, we sought to determine if the starburst amacrine cells, which are the main cellular type involved in motion direction selectivity, are degenerated in PD and if the dopaminergic system is related to this degeneration. Methods Human eyes from control ( n = 10) and PD ( n = 9) donors were available for this study. Using immunohistochemistry and confocal microscopy, we quantified starburst amacrine cell density (choline acetyltransferase [ChAT]-positive cells) and the relationship between these cells and dopaminergic amacrine cells (tyrosine hydroxylase-positive cells and vesicular monoamine transporter-2-positive presynapses) in cross-sections and wholemount retinas. Results First, we found two different ChAT amacrine populations in the human retina that presented different ChAT immunoreactivity intensity and different expression of calcium-binding proteins. Both populations are affected in PD and their density is reduced compared to controls. Also, we report, for the first time, synaptic contacts between dopaminergic amacrine cells and ChAT-positive cells in the human retina. We found that, in PD retinas, there is a reduction of the dopaminergic synaptic contacts into ChAT cells. Conclusions Taken together, this work indicates degeneration of starburst amacrine cells in PD related to dopaminergic degeneration and that dopaminergic amacrine cells could modulate the function of starburst amacrine cells. Since motion perception circuitries are affected in PD, their assessment using visual tests could provide new insights into the diagnosis of PD. |
ArticleNumber | 17 |
Author | Lax, Pedro Cuenca, Nicolás Sánchez-Sáez, Xavier Ortuño-Lizarán, Isabel Sánchez-Castillo, Carla |
Author_xml | – sequence: 1 givenname: Xavier surname: Sánchez-Sáez fullname: Sánchez-Sáez, Xavier organization: Department of Physiology, Genetics and Microbiology, University of Alicante – sequence: 2 givenname: Isabel surname: Ortuño-Lizarán fullname: Ortuño-Lizarán, Isabel organization: Department of Physiology, Genetics and Microbiology, University of Alicante – sequence: 3 givenname: Carla surname: Sánchez-Castillo fullname: Sánchez-Castillo, Carla organization: Department of Physiology, Genetics and Microbiology, University of Alicante – sequence: 4 givenname: Pedro surname: Lax fullname: Lax, Pedro organization: Department of Physiology, Genetics and Microbiology, University of Alicante, Alicante Institute for Health and Biomedical Research (ISABIAL) – sequence: 5 givenname: Nicolás orcidid: 0000-0002-6767-5710 surname: Cuenca fullname: Cuenca, Nicolás email: cuenca@ua.es organization: Department of Physiology, Genetics and Microbiology, University of Alicante, Alicante Institute for Health and Biomedical Research (ISABIAL), Ramón Margalef Institute, University of Alicante |
BookMark | eNp9UUtuFDEUtFCQCCEXYOUDpMHd_nTPEkV8IkUCKbC2nu3Xg4duu2V7Ruod1-AM3IqT4MkgRFjEG5fKqiq56jk5CzEgIS9b9qptB_U6C8a4bFjHmwrE0KxPyHnHRN9sWjmc_YOfkcucd6wexaRS8pz8vCuQzD7lQmEGm3xAanGa8hX14RCnA7oK6MHnPUx0jsXHQBdMFpcjvKJTzEjLV_SJ5jVAZW0VLPtCxxRn6uICczVN28o_TKAQHHW4xfoKBY8xnyB98yHH8Ov7j0ydzwjVfYHiMZT8gjwdYcp4-ee-IF_evf18_aG5_fj-5vrNbWM7odZmQCMdU64beiWMkFwyMJY5boZRyZb3YA2qzTg4KUQnrJCtHDeudjR2ahTIL8jNyddF2Okl-RnSqiN4fU_EtNWQ6j8n1Iz1XI3G9MYIIazadBZFbwdmuVEORPXqTl42xZwTjn_9WqaP6-nTerqup-_X02sVDf-JrC9w7Lsk8NPjUn6S5poTtpj0Lu5TqHU9pvoNw-G3Xg |
CitedBy_id | crossref_primary_10_1212_WNL_0000000000207780 crossref_primary_10_1002_glia_24612 crossref_primary_10_3389_fphar_2023_1288894 crossref_primary_10_1186_s40035_023_00360_2 crossref_primary_10_1007_s00429_024_02799_z crossref_primary_10_31083_j_fbl2909337 |
Cites_doi | 10.1016/S0006-8993(02)04049-0 10.1126/science.155.3764.841 10.1016/j.ajo.2013.09.028 10.1007/s00401-018-01956-z 10.1097/00006324-199404000-00002 10.1017/S0952523819000087 10.1111/jnc.13144 10.1002/mds.22868 10.1016/j.neuropsychologia.2015.11.019 10.1016/j.tins.2005.06.002 10.1002/ana.24182 10.1016/0042-6989(92)90063-O 10.1093/brain/118.3.771 10.1016/S0042-6989(97)00402-1 10.1002/cne.903100210 10.1523/JNEUROSCI.1784-18.2018 10.1136/jnnp.47.7.673 10.1016/j.devcel.2022.02.018 10.1093/brain/awp068 10.1146/annurev-neuro-072116-031335 10.1016/j.preteyeres.2020.100844 10.1002/cne.902850104 10.1212/WNL.0000000000006157 10.1093/brain/110.6.1675 10.1002/cne.903210106 10.1038/nature06739 10.1038/s41467-022-30405-5 10.1038/nature00931 10.1016/j.tins.2011.08.002 10.1016/j.cell.2021.04.048 10.1093/braincomms/fcab109 10.1016/j.jchemneu.2016.11.003 10.1038/nature22818 10.1371/journal.pone.0054667 10.1038/nrn3165 10.1016/j.parkreldis.2022.06.018 10.1016/j.preteyeres.2020.100938 10.1111/neup.12189 10.1038/s41598-020-66497-6 10.1002/ana.25897 10.1523/JNEUROSCI.07-12-04115.1987 10.1002/mds.27392 10.1001/archophthalmol.2009.106 10.1523/JNEUROSCI.5436-03.2004 10.1186/s40478-018-0596-z 10.1038/s41598-019-48388-7 10.1002/cne.20761 10.1002/mds.21586 10.1038/s41582-022-00618-9 10.1212/01.wnl.0000191565.11065.11 10.1016/0168-5597(95)00169-7 10.1371/journal.pone.0074439 10.1016/j.nbd.2011.06.009 10.1016/j.parkreldis.2019.04.023 10.1016/S1474-4422(06)70600-7 10.3233/JPD-191830 10.1016/S0896-6273(01)00316-6 10.1002/mds.870070308 |
ContentType | Journal Article |
Copyright | The Author(s) 2023 corrected publication 2023 |
Copyright_xml | – notice: The Author(s) 2023 corrected publication 2023 |
DBID | C6C AAYXX CITATION DOA |
DOI | 10.1186/s40035-023-00348-y |
DatabaseName | Springer Nature OA Free Journals CrossRef Directory of Open Access Journals |
DatabaseTitle | CrossRef |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2047-9158 |
EndPage | 16 |
ExternalDocumentID | oai_doaj_org_article_00736fbb7bb444c692ce47c80c3b6da4 10_1186_s40035_023_00348_y |
GrantInformation_xml | – fundername: Ministerio de Ciencia e Innovación grantid: FEDER-PID 2019-106230RB-I00; FEDER-PID 2019-106230RB-I00 funderid: http://dx.doi.org/10.13039/501100004837 – fundername: Ministerio de Universidades grantid: FPU16/04114 – fundername: Conselleria de Innovación, Universidades, Ciencia y Sociedad Digital, Generalitat Valenciana grantid: IDIFEDER/2017/064; PROMETEO/2021/024; PROMETEO/2021/024; APOSTD/2020/245 funderid: http://dx.doi.org/10.13039/501100016386 – fundername: Michael J. Fox Foundation for Parkinson's Research funderid: http://dx.doi.org/10.13039/100000864 – fundername: FARPE-FUNDALUCE – fundername: Instituto de Salud Carlos III grantid: RETICS-FEDER RD16/0008/0016 funderid: http://dx.doi.org/10.13039/501100004587 – fundername: Es Retina Asturias grantid: 2019/00286/001; 2019/00286/001 |
GroupedDBID | 0R~ 5VS 7X7 8FI 8FJ AAJSJ AASML ABUWG ACGFS ACIHN ACMJI ADBBV ADRAZ ADUKV AEAQA AFKRA AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU EBLON EBS FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR IHW INH INR ITC KQ8 LGEZI LOTEE M48 NADUK NXXTH OK1 PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PUEGO RBZ RNS ROL RPM RSV SBL SOJ UKHRP AAYXX ALIPV CITATION |
ID | FETCH-LOGICAL-c246y-8eb5d06d28764b45350abc0d3b8f65137acbe69f8d54424c4515f9d047f26f4e3 |
IEDL.DBID | M48 |
ISSN | 2047-9158 |
IngestDate | Wed Aug 27 01:22:25 EDT 2025 Tue Jul 01 03:25:29 EDT 2025 Thu Apr 24 22:53:35 EDT 2025 Sat Sep 06 07:18:57 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | ChAT amacrine cells Human retina Retinal neurodegeneration Dopaminergic amacrine cells Parkinson’s disease |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c246y-8eb5d06d28764b45350abc0d3b8f65137acbe69f8d54424c4515f9d047f26f4e3 |
ORCID | 0000-0002-6767-5710 |
OpenAccessLink | https://doi.org/10.1186/s40035-023-00348-y |
PageCount | 16 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_00736fbb7bb444c692ce47c80c3b6da4 crossref_primary_10_1186_s40035_023_00348_y crossref_citationtrail_10_1186_s40035_023_00348_y springer_journals_10_1186_s40035_023_00348_y |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20230403 |
PublicationDateYYYYMMDD | 2023-04-03 |
PublicationDate_xml | – month: 4 year: 2023 text: 20230403 day: 3 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London |
PublicationTitle | Translational neurodegeneration |
PublicationTitleAbbrev | Transl Neurodegener |
PublicationYear | 2023 |
Publisher | BioMed Central BMC |
Publisher_xml | – name: BioMed Central – name: BMC |
References | NK Archibald (348_CR1) 2009; 132 KR Chaudhuri (348_CR2) 2010; 25 TG Beach (348_CR30) 2015; 35 U Grunert (348_CR33) 2020; 78 E Marrocco (348_CR44) 2020; 10 P Martinez-Martin (348_CR3) 2007; 22 D Regan (348_CR5) 1984; 47 EY Uc (348_CR10) 2005; 65 G Debertin (348_CR40) 2015; 134 E Garcia-Martin (348_CR58) 2014; 157 CA Wang (348_CR11) 2016; 80 MS Sung (348_CR61) 2019; 9 R Netser (348_CR12) 2021; 11 RW Rodieck (348_CR26) 1989; 285 H Kolb (348_CR39) 1991; 310 OS Dhande (348_CR51) 2019; 39 RD Jones (348_CR4) 1992; 7 I Ortuño-Lizarán (348_CR15) 2020; 88 A Chrysou (348_CR60) 2019; 64 RA Cliburn (348_CR34) 2017; 83–84 J Ahn (348_CR59) 2018; 91 Y Hao (348_CR32) 2021; 184 AS Mauss (348_CR19) 2017; 40 I Ortuño-Lizarán (348_CR17) 2018; 33 L Campello (348_CR41) 2013; 8 S Sabbah (348_CR50) 2017; 546 I Bodis-Wollner (348_CR6) 1987; 110 348_CR28 348_CR29 DI Vaney (348_CR54) 2012; 13 T Euler (348_CR20) 2002; 418 P Witkovsky (348_CR35) 2004; 24 CW Oyster (348_CR48) 1979; 155 S Moritoh (348_CR53) 2013; 8 AH Kashani (348_CR14) 2021; 83 ED Thomas (348_CR31) 2021; 57 I Bodis-Wollner (348_CR18) 2014; 75 RH Masland (348_CR23) 2005; 28 N Cuenca (348_CR22) 2003; 964 P Calabresi (348_CR36) 2006; 5 N Cuenca (348_CR42) 2005; 493 T Voigt (348_CR38) 1987; 7 ME Hajee (348_CR57) 2009; 127 BA Haug (348_CR8) 1995; 118 BC Regan (348_CR7) 1998; 38 W Wei (348_CR46) 2011; 34 K Yoshida (348_CR21) 2001; 30 RW Rodieck (348_CR25) 1992; 321 NI Bohnen (348_CR37) 2021; 3 YJ Kim (348_CR52) 2022; 13 JY Lee (348_CR56) 2022; 18 J Esteve-Rudd (348_CR43) 2011; 44 348_CR47 GL Trick (348_CR9) 1994; 71 L Veys (348_CR45) 2019; 137 IJ Kim (348_CR49) 2008; 452 I Ortuño-Lizarán (348_CR16) 2018; 6 AJ Chandra (348_CR24) 2019; 36 LGM Mello (348_CR55) 2022; 101 GD Guiloff (348_CR27) 1992; 32 M Tagliati (348_CR13) 1996; 100 |
References_xml | – volume: 964 start-page: 21 issue: 1 year: 2003 ident: 348_CR22 publication-title: Brain Res doi: 10.1016/S0006-8993(02)04049-0 – ident: 348_CR47 – volume: 155 start-page: 841 issue: 3764 year: 1979 ident: 348_CR48 publication-title: Science doi: 10.1126/science.155.3764.841 – volume: 157 start-page: 470 issue: 2 year: 2014 ident: 348_CR58 publication-title: Am J Ophthalmol doi: 10.1016/j.ajo.2013.09.028 – ident: 348_CR28 – volume: 137 start-page: 379 issue: 3 year: 2019 ident: 348_CR45 publication-title: Acta Neuropathol doi: 10.1007/s00401-018-01956-z – volume: 71 start-page: 242 issue: 4 year: 1994 ident: 348_CR9 publication-title: Optom Vis Sci doi: 10.1097/00006324-199404000-00002 – volume: 36 start-page: E009 year: 2019 ident: 348_CR24 publication-title: Vis Neurosci doi: 10.1017/S0952523819000087 – volume: 134 start-page: 416 issue: 3 year: 2015 ident: 348_CR40 publication-title: J Neurochem doi: 10.1111/jnc.13144 – volume: 25 start-page: 704 issue: 6 year: 2010 ident: 348_CR2 publication-title: Mov Disord doi: 10.1002/mds.22868 – volume: 80 start-page: 176 year: 2016 ident: 348_CR11 publication-title: Neuropsychologia doi: 10.1016/j.neuropsychologia.2015.11.019 – volume: 28 start-page: 395 issue: 8 year: 2005 ident: 348_CR23 publication-title: Trends Neurosci doi: 10.1016/j.tins.2005.06.002 – volume: 75 start-page: 964 issue: 6 year: 2014 ident: 348_CR18 publication-title: Ann Neurol doi: 10.1002/ana.24182 – volume: 32 start-page: 2023 issue: 11 year: 1992 ident: 348_CR27 publication-title: Vision Res doi: 10.1016/0042-6989(92)90063-O – volume: 118 start-page: 771 issue: Pt 3 year: 1995 ident: 348_CR8 publication-title: Brain doi: 10.1093/brain/118.3.771 – volume: 38 start-page: 3427 issue: 21 year: 1998 ident: 348_CR7 publication-title: Vision Res doi: 10.1016/S0042-6989(97)00402-1 – volume: 310 start-page: 267 issue: 2 year: 1991 ident: 348_CR39 publication-title: J Comp Neurol doi: 10.1002/cne.903100210 – volume: 39 start-page: 78 issue: 1 year: 2019 ident: 348_CR51 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.1784-18.2018 – volume: 47 start-page: 673 issue: 7 year: 1984 ident: 348_CR5 publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp.47.7.673 – volume: 57 start-page: 820 issue: 6 year: 2021 ident: 348_CR31 publication-title: Dev Cell doi: 10.1016/j.devcel.2022.02.018 – volume: 132 start-page: 1128 issue: Pt 5 year: 2009 ident: 348_CR1 publication-title: Brain doi: 10.1093/brain/awp068 – volume: 40 start-page: 211 year: 2017 ident: 348_CR19 publication-title: Annu Rev Neurosci doi: 10.1146/annurev-neuro-072116-031335 – volume: 78 start-page: 100844 year: 2020 ident: 348_CR33 publication-title: Prog Retin Eye Res doi: 10.1016/j.preteyeres.2020.100844 – volume: 285 start-page: 18 issue: 1 year: 1989 ident: 348_CR26 publication-title: J Comp Neurol doi: 10.1002/cne.902850104 – volume: 91 start-page: e1003 issue: 11 year: 2018 ident: 348_CR59 publication-title: Neurology doi: 10.1212/WNL.0000000000006157 – volume: 110 start-page: 1675 issue: Pt 6 year: 1987 ident: 348_CR6 publication-title: Brain doi: 10.1093/brain/110.6.1675 – volume: 321 start-page: 46 issue: 1 year: 1992 ident: 348_CR25 publication-title: J Comp Neurol doi: 10.1002/cne.903210106 – volume: 452 start-page: 478 issue: 7186 year: 2008 ident: 348_CR49 publication-title: Nature doi: 10.1038/nature06739 – volume: 13 start-page: 2862 issue: 1 year: 2022 ident: 348_CR52 publication-title: Nat Commun doi: 10.1038/s41467-022-30405-5 – volume: 418 start-page: 845 issue: 6900 year: 2002 ident: 348_CR20 publication-title: Nature doi: 10.1038/nature00931 – volume: 34 start-page: 638 issue: 12 year: 2011 ident: 348_CR46 publication-title: Trends Neurosci doi: 10.1016/j.tins.2011.08.002 – volume: 184 start-page: 3573 issue: 13 year: 2021 ident: 348_CR32 publication-title: Cell doi: 10.1016/j.cell.2021.04.048 – volume: 3 start-page: fcab109 issue: 2 year: 2021 ident: 348_CR37 publication-title: Brain Commun doi: 10.1093/braincomms/fcab109 – volume: 83–84 start-page: 82 year: 2017 ident: 348_CR34 publication-title: J Chem Neuroanat doi: 10.1016/j.jchemneu.2016.11.003 – volume: 546 start-page: 492 issue: 7659 year: 2017 ident: 348_CR50 publication-title: Nature doi: 10.1038/nature22818 – volume: 8 start-page: e54667 issue: 1 year: 2013 ident: 348_CR53 publication-title: PLoS ONE doi: 10.1371/journal.pone.0054667 – volume: 13 start-page: 194 issue: 3 year: 2012 ident: 348_CR54 publication-title: Nat Rev Neurosci doi: 10.1038/nrn3165 – volume: 101 start-page: 90 year: 2022 ident: 348_CR55 publication-title: Parkinsonism Relat Disord doi: 10.1016/j.parkreldis.2022.06.018 – volume: 83 start-page: 100938 year: 2021 ident: 348_CR14 publication-title: Prog Retin Eye Res doi: 10.1016/j.preteyeres.2020.100938 – volume: 35 start-page: 354 issue: 4 year: 2015 ident: 348_CR30 publication-title: Neuropathology doi: 10.1111/neup.12189 – volume: 10 start-page: 9619 issue: 1 year: 2020 ident: 348_CR44 publication-title: Sci Rep doi: 10.1038/s41598-020-66497-6 – volume: 88 start-page: 893 issue: 5 year: 2020 ident: 348_CR15 publication-title: Ann Neurol doi: 10.1002/ana.25897 – volume: 7 start-page: 4115 issue: 12 year: 1987 ident: 348_CR38 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.07-12-04115.1987 – volume: 33 start-page: 1315 issue: 8 year: 2018 ident: 348_CR17 publication-title: Mov Disord doi: 10.1002/mds.27392 – volume: 127 start-page: 737 issue: 6 year: 2009 ident: 348_CR57 publication-title: Arch Ophthalmol doi: 10.1001/archophthalmol.2009.106 – volume: 24 start-page: 4242 issue: 17 year: 2004 ident: 348_CR35 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.5436-03.2004 – volume: 6 start-page: 90 issue: 1 year: 2018 ident: 348_CR16 publication-title: Acta Neuropathol Commun doi: 10.1186/s40478-018-0596-z – volume: 9 start-page: 11832 issue: 1 year: 2019 ident: 348_CR61 publication-title: Sci Rep doi: 10.1038/s41598-019-48388-7 – volume: 493 start-page: 261 issue: 2 year: 2005 ident: 348_CR42 publication-title: J Comp Neurol doi: 10.1002/cne.20761 – volume: 22 start-page: 1623 issue: 11 year: 2007 ident: 348_CR3 publication-title: Mov Disord doi: 10.1002/mds.21586 – volume: 18 start-page: 203 issue: 4 year: 2022 ident: 348_CR56 publication-title: Nat Rev Neurol doi: 10.1038/s41582-022-00618-9 – volume: 65 start-page: 1907 issue: 12 year: 2005 ident: 348_CR10 publication-title: Neurology doi: 10.1212/01.wnl.0000191565.11065.11 – volume: 100 start-page: 1 issue: 1 year: 1996 ident: 348_CR13 publication-title: Electroencephalogr Clin Neurophysiol doi: 10.1016/0168-5597(95)00169-7 – volume: 8 start-page: e74439 issue: 9 year: 2013 ident: 348_CR41 publication-title: PLoS ONE doi: 10.1371/journal.pone.0074439 – ident: 348_CR29 – volume: 44 start-page: 102 issue: 1 year: 2011 ident: 348_CR43 publication-title: Neurobiol Dis doi: 10.1016/j.nbd.2011.06.009 – volume: 64 start-page: 40 year: 2019 ident: 348_CR60 publication-title: Parkinsonism Relat Disord doi: 10.1016/j.parkreldis.2019.04.023 – volume: 5 start-page: 974 issue: 11 year: 2006 ident: 348_CR36 publication-title: Lancet Neurol doi: 10.1016/S1474-4422(06)70600-7 – volume: 11 start-page: 251 issue: 1 year: 2021 ident: 348_CR12 publication-title: J Parkinsons Dis doi: 10.3233/JPD-191830 – volume: 30 start-page: 771 issue: 3 year: 2001 ident: 348_CR21 publication-title: Neuron doi: 10.1016/S0896-6273(01)00316-6 – volume: 7 start-page: 232 issue: 3 year: 1992 ident: 348_CR4 publication-title: Mov Disord doi: 10.1002/mds.870070308 |
SSID | ssj0000605665 |
Score | 2.2638304 |
Snippet | Background
The main clinical symptoms characteristic of Parkinson’s disease (PD) are bradykinesia, tremor, and other motor deficits. However, non-motor... Abstract Background The main clinical symptoms characteristic of Parkinson’s disease (PD) are bradykinesia, tremor, and other motor deficits. However,... |
SourceID | doaj crossref springer |
SourceType | Open Website Enrichment Source Index Database Publisher |
StartPage | 1 |
SubjectTerms | Biomedical and Life Sciences Biomedicine ChAT amacrine cells Dopaminergic amacrine cells Human retina Neurology Neurosciences Parkinson’s disease Retinal neurodegeneration |
SummonAdditionalLinks | – databaseName: Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NSiQxEA7iYfEi6x876koO3nYaM92VdPq4K4oIelrBW8jvImg7mB5hbr6Gz-Bb-SRbSfcMyoJe9taEpKupqk5VpVJfEXIIwB3kip5aQgGAAUqjHRS2LEPNeHBlRue_uBRnV3B-za_ftPpKd8J6eOCecUcplSSCMbUxAGBFU1oPtZXMVkY4nZFAWcPeBFP9HoyGXfBFlYwURxEyOiOaqCJhsshi_s4SZcD-f7Kh2cicfiXrg3dIf_ZftUFWfLtJvlwM-e8t8oK-YWJD7Ki-0zZV7tF09B7H9KbFjebRO3ygjzdxhq_pO_TQ6fLuypje3kdPc3KAxnmrcdTigumso6nOhDoMoe9yOSCOv6dAdeuo838yTHXnE5lUMZ2Lx16fniMdUj10QGqN2-Tq9OT38VkxtFtAwYCYF9Ib7phwGEMJMMArzrSxzFVGBsEnVa2t8aIJ0nGUKVhAVyg0jkEdShHAVztktb1v_TdCJw1KRhjuLbMgq4mGqmTWu5BOnAJjIzJZsF7ZAYs8tcS4VTkmkUL14lIoLpXFpeYj8mO5ZtojcXw4-1eS6HJmQtHOA6hbatAt9Zlujch4oQ9q-LXjBzR3_wfNPbJWZiWFglX7ZLV7mPnv6Pd05iCr-F9lvwHY priority: 102 providerName: Directory of Open Access Journals – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3dShwxFA7Vgngjba24_SMXvesOZmdOMpnLdqlIwV5V8C7kVwQdFzO7sHe-Rp_Bt_JJPMlml0qL0LshJBMm30lyTs58Xwj5DMAdZEZPK6ECwACl0w4qW9ehZTy4Oqvzn_4UJ2fw45yfF5mcxIX5M38_keIoQhZVxJ2lSlIqslpukZccF95kzVMx3ZynMPTLheBrXsw_mz7Ze7JE_1_5z7ytHL8ie8UfpF9XAL4mL3z_huycloz3PrlHbzB9eByovtY2cfVoOmyPY3rZ49Ky8A4f6OIyzvE1qzt56Gzzt8qYXt1ET3M6gMZlr7HUYoPZfKCJWUIdBs3XmQCI5U97oLp31PmLLEw9-NRN4khnutjD3e9IS3KHFm3W-JacHX__NT2pygULCAWIZSW94Y4Jh1GTAAO84Uwby1xjZBA4yK22xosuSMcRRbCAzk_oHIM21CKAbw7Idn_T-0NCJ53TIAz3llmQzURDUzPrXUhnTIGxEZmsh17Zoj6eLsG4UjkKkUKt4FIIl8pwqeWIfNm0ma20N56t_S0huqmZdLNzAZqTKtNQpcSkCMa0xgCAFV1tPbRWMtsYgV8wIuO1PagymeMzfb77v-rvyW6dzREq1nwg28Pt3H9En2Ywn7IxPwLMPvIw priority: 102 providerName: Springer Nature |
Title | Starburst amacrine cells, involved in visual motion perception, lose their synaptic input from dopaminergic amacrine cells and degenerate in Parkinson’s disease patients |
URI | https://link.springer.com/article/10.1186/s40035-023-00348-y https://doaj.org/article/00736fbb7bb444c692ce47c80c3b6da4 |
Volume | 12 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1La9wwEBZ5QOmlNH3Q7WPRobeuW9keyfKhlO2SEBbSS7uQm7FeIbDxbtfeUN_6N_ob-q_6SzqS7YWQEMjNCEuyZ0aaGY3mG0LeA3ADIaMnkxABoIOSlwYinSQuY9yZJKDzn30TpwuYn_PzPTKUO-oJWN_p2vl6UovN8uOvn-0XXPCfw4KX4lMNAXgRtU_k4VZk1O6TwxAv8lf5enO_25lR3YfqkokHKMhjLoc8mjuHuaGrAqT_rXhpUEMnT8mT3n6k047hR2TPVs_Io7M-Qv6c_EXr0ROqbmh5VWqf20f94Xw9oZcVbkXX1uADvb6stzhMV8OHrne3WyZ0uaotDeEDWrdVia0aO6y3DfWZKNSgk30VEgax_eYMtKwMNfYiAFk31k_jc6pDetm_339q2geDaI_lWr8gi5PjH7PTqC_IgKwD0UbSKm6YMOhlCVDAU85KpZlJlXSCx2lWamVF7qThyHXQgMaSyw3S2iXCgU1fkoNqVdlXhMa5KUEobjXTINO4hDRh2hrnz6QcYyMSD6QvdI9W7otmLIvgtUhRdOwqkF1FYFfRjsiHXZ91h9Vx79tfPUd3b3qc7dCw2lwU_bItfCBTOKUypQBAizzRFjItmU6VwD8YkckgD8Ugu_fM-fpBX_iGPE6CNELE0rfkoNls7Ts0gRo1JofT6fz7fEz2Z2I2DgcJ4yDr_wHQoAWX |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3LbtQwFLWgSMAG8RTD0wt2TISTXDvOEkZUA3S6aqXuLD9RpTYd4Uyl2fEbfAN_xZdw7fGMqECV2EWWHcs-1_G9vjnHhLwB4A4yo6eTUAFggNJrB5VtmtAxHlyT1fkXh2J-DJ9P-EmRyUlcmD_z97UU7yJkUUXcWaokpSKr9U1yK2Uuk07-TMx25ykM_XIh-JYX88-mV_aeLNH_V_4zbyv798m94g_S9xsAH5AbfnhIbi9KxvsR-YneYBp4HKk-1zZx9Wg6bI9Tejrgp-XSO3ygl6dxha_Z3MlDl7u_Vab07CJ6mtMBNK4HjaUWGyxXI03MEuowaD7PBEAsv9oD1YOjzn_NwtSjT90kjnSmi_36_iPSktyhRZs1PibH-x-PZvOqXLCAUIBYV9Ib7phwGDUJMMBbzrSxzLVGBsHrttPWeNEH6TiiCBbQ-Qm9Y9CFRgTw7ROyN1wM_imhde80CMO9ZRZkW2toG2a9C-mMKTA2IfV26pUt6uPpEowzlaMQKdQGLoVwqQyXWk_I212b5UZ749raHxKiu5pJNzsXoDmpsgxVSkyKYExnDABY0TfWQ2cls60ROIIJmW7tQZXFHK_p89n_VX9N7syPFgfq4NPhl-fkbpNNEyrWviB747eVf4n-zWheZcP-DVgG9R8 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3LatwwFBVtAqGb0iedPrXormOisa9keTl9DOm0CYU2kJ3QMwQSzxB7ArPrb_Qb-lf9kl7JmqGhJdCdEZKFdSTrPnSOCHkNwB0kRk8toQBAB6XRDgpblqFmPLgyqfMfHomDY5if8JM_WPzptPsmJTlwGqJKU9vvL10YlrgU-x0kqUXcb4oosCKL9W2yK3nToPu1O53Ov863cRaG9roQfMOX-Wfja3tSku7_Ky-atpvZPXI324l0OgB7n9zy7QOyd5gz4Q_JT7QS44B0PdUX2kYOH41B-G5Mz1r85Vx5hw_06qxb4WuGu3rocnuKZUzPF52nKU1Au3WrsdRig-Wqp5FxQh060xeJGIjl13ugunXU-dMkWN372E3kTica2a_vPzqakz40a7Z2j8jx7MO3dwdFvngBIQKxLqQ33DHh0JsSYIBXnGljmauMDIJPqlpb40UTpOOILlhAoyg0jkEdShHAV4_JTrto_RNCJ43TIAz3llmQ1URDVTLrXYixp8DYiEw2Q69sViWPl2Ocq-SdSKEGuBTCpRJcaj0ib7ZtloMmx42130ZEtzWjnnYqWFyeqrw8VUxYimBMbQwAWNGU1kNtJbOVEfgFIzLezAeVF3l3Q59P_6_6K7L35f1Mff549OkZuVOmmQkFq56Tnf5y5V-g2dObl3lm_wavEf7d |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Starburst+amacrine+cells%2C+involved+in+visual+motion+perception%2C+lose+their+synaptic+input+from+dopaminergic+amacrine+cells+and+degenerate+in+Parkinson%E2%80%99s+disease+patients&rft.jtitle=Translational+neurodegeneration&rft.au=S%C3%A1nchez-S%C3%A1ez%2C+Xavier&rft.au=Ortu%C3%B1o-Lizar%C3%A1n%2C+Isabel&rft.au=S%C3%A1nchez-Castillo%2C+Carla&rft.au=Lax%2C+Pedro&rft.date=2023-04-03&rft.issn=2047-9158&rft.eissn=2047-9158&rft.volume=12&rft.issue=1&rft_id=info:doi/10.1186%2Fs40035-023-00348-y&rft.externalDBID=n%2Fa&rft.externalDocID=10_1186_s40035_023_00348_y |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2047-9158&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2047-9158&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2047-9158&client=summon |